AdvocacyRSS6 days ago
Talking to family and friends about your Parkinson's diagnosis doesn't have to be complicated. The key is to keep explanations simple and be honest about what you're experiencing. When people understand what's really going on, they're better able to help and support you in meaningful ways.
WHY IT MATTERSClear communication with your support network helps reduce isolation and ensures family and friends can provide practical help tailored to your actual needs as your condition changes.
NewsRSS6 days ago
Upsher-Smith Laboratories created two new websites to help people with Duchenne muscular dystrophy (DMD) who are using a medicine called Kymbee. One website is made for parents and caregivers of children with DMD and includes tips for talking to doctors and instructions for starting the treatment.
WHY IT MATTERSIf your child has DMD and is considering or starting Kymbee treatment, these new websites provide free resources to help you understand the medication and communicate with your healthcare team.
ResearchPUBMEDApr 20
Researchers in New Zealand interviewed 15 people with rare diseases and their caregivers to understand what it's like to get diagnosed and treated. They found that patients often have to fight hard to get answers and support because doctors don't know much about rare diseases. The study shows that people with rare diseases face similar challenges, even though their specific conditions are very different.
WHY IT MATTERSThis research directly documents the real-world barriers that rare disease patients face in accessing diagnosis and care in New Zealand, providing evidence that could help healthcare systems improve support for the estimated 300 million people worldwide living with rare disorders.
ResearchPUBMEDApr 17
Researchers in Saudi Arabia studied how different factors affect the stress and well-being of parents who have children with three rare genetic diseases: cystic fibrosis, congenital adrenal hyperplasia, and Duchenne muscular dystrophy. They surveyed 107 parents and found that things like whether parents work, family income, and cultural factors all play a role in how well parents cope with having a sick child. Understanding these factors can help doctors and support services better help families dealing with rare diseases.
WHY IT MATTERSIf you're a parent of a child with CF, CAH, or DMD, this research identifies specific factors affecting your quality of life—such as employment status and family support—that healthcare providers can now address to improve your family's well-being.
Clinical trialCLINICALTRIALSApr 14
Researchers are looking for young adults ages 15-25 with rare genetic disabilities to join a study about getting jobs and education. The study will follow 300 participants and examine the challenges these young people face when trying to go to school, get internships, or find work. Many young people with rare genetic diseases struggle with these opportunities because of their condition and lack of support.
WHY IT MATTERSThis trial directly addresses employment and education barriers that young adults with rare genetic disabilities face — areas where they typically have the fewest resources and support.
ResearchCLINICALTRIALSApr 14
Researchers completed a small study with 14 children who have rare diseases and their parents to test whether a social robot could help families cope better. The robot was designed to provide support and improve relationships between parents and children while reducing stress and worry. The study looked at whether families found the robot helpful and acceptable to use in their daily lives.
WHY IT MATTERSThis completed trial demonstrates a novel approach to family-centered support for rare disease patients—social robots may offer accessible emotional and relational support when specialized mental health resources for rare disease families are limited.
ResearchPUBMEDApr 10
This study talked to 10 parents in South Africa whose children have rare diseases to understand what challenges they face as caregivers. The parents said they struggle with stress, worry about their children's health, and sometimes feel tired and sad. The researchers want doctors and hospitals to better understand what caregivers go through so they can offer more help and support.
WHY IT MATTERSIf you're caring for a child with a rare disease, this research validates that your struggles are real and documented — and shows healthcare systems need to provide better caregiver support services.
Clinical trialUNITERAREApr 5
Researchers are testing whether children and young adults can use robotic leg braces (called exoskeletons) in their daily lives to help them walk and move around. An exoskeleton is a wearable machine that supports your legs and helps you move if you have difficulty walking. This study will see if these devices can become common tools that help young people with mobility challenges do everyday activities.
WHY IT MATTERSThis trial is recruiting children and young adults with lower limb mobility challenges — if you or your child has difficulty walking due to a neurological or muscular condition, this could offer access to cutting-edge assistive technology at no cost through a major research institution.
Clinical trialUNITERAREApr 3
Researchers at Columbia University are testing a new program called MyPEEPS Mobile Plus to help young men who have sex with men prevent HIV infection. The program uses multiple approaches, including mobile technology and community support, to reduce HIV risk. This trial is now accepting participants and will run through 2026.
WHY IT MATTERSThis trial is actively recruiting young MSM (men who have sex with men) ages 18-24 who want to learn evidence-based HIV prevention strategies through a mobile app and peer support program.
ResearchPUBMEDApr 3
Researchers tested whether artificial intelligence chatbots like ChatGPT could diagnose rare genetic diseases by comparing them to a traditional diagnostic tool called Exomiser. They tested seven different AI models on over 5,000 real patient cases. The study found that even the best AI chatbots were not as accurate as the existing diagnostic tool at identifying the correct disease.
WHY IT MATTERSIf you're waiting for a diagnosis for a rare genetic disease, this research shows that AI chatbots alone shouldn't replace traditional diagnostic tools—your doctor should continue using proven methods alongside any new technology.
ResearchPUBMEDApr 1
Researchers in Turkey tested a new questionnaire called the Parental Needs Scale for Rare Diseases to measure what parents of children with rare diseases need most. The study included 264 parents and used statistical tests to make sure the questionnaire works well and gives consistent results. This tool can help doctors and support programs better understand and meet the needs of families dealing with rare diseases.
WHY IT MATTERSThis validated assessment tool enables healthcare systems to systematically identify and address the specific economic, emotional, and physical support needs of parents caring for children with rare diseases, potentially improving family quality of life and care outcomes.
ResearchCLINICALTRIALSMar 30
This study is looking for 2,800 people to help researchers understand how being a caregiver affects a person's health and stress levels over time. The study includes caregivers of people with rare diseases like Batten disease, Tay-Sachs disease, and other inherited metabolic disorders, as well as caregivers of people with undiagnosed diseases. By learning more about caregiver stress, researchers hope to find ways to better support the millions of unpaid family caregivers in the U.S.
WHY IT MATTERSIf you or a family member care for someone with a rare inherited metabolic disorder, Batten disease, Tay-Sachs, or an undiagnosed disease, this study directly addresses the health challenges caregivers face and could lead to better support resources.
ResearchCLINICALTRIALSMar 30
Researchers at Children's National completed a study testing a new support program for parents of children with rare diseases. The program, called Rare Group Problem Management Plus, brought parents together once a week for 5 weeks to help them manage stress, anxiety, and emotional challenges. The small study included 8 parents and focused on teaching practical coping skills in a group setting where everyone had similar experiences.
WHY IT MATTERSThis completed trial demonstrates that group-based support programs specifically designed for parents of children with rare conditions can address the significant mental health burden these families face, potentially offering a scalable model for other rare disease communities.